N/a
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-Intraday pattern: Mountain
-Levels: 32, 32.50, 33
First test long of 32.50 level with half dollar confluence
Didn't want to get to full size as time was 11am and stock was illiquid. Got two lots in the 32.50's and took profits on half and scratched the other as it was having a hard time bouncing.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-04-08 11:14:53 | MRNA | buy | $32.570 | long |
2020-04-08 11:14:56 | MRNA | buy | $32.510 | long |
2020-04-08 11:17:41 | MRNA | sell | $32.740 | long |
2020-04-08 11:18:41 | MRNA | sell | $32.600 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!